PortfoliosLab logoPortfoliosLab logo
BIOPX vs. AWYIX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BIOPX vs. AWYIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Baron Opportunity Fund (BIOPX) and CIBC Atlas Equity Income Fund (AWYIX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BIOPX achieves a 11.24% return, which is significantly higher than AWYIX's 2.05% return.


BIOPX

1D
-0.05%
1M
9.24%
YTD
11.24%
6M
15.26%
1Y
29.20%
3Y*
28.25%
5Y*
11.77%
10Y*
21.51%

AWYIX

1D
0.17%
1M
1.77%
YTD
2.05%
6M
2.22%
1Y
10.13%
3Y*
12.78%
5Y*
7.78%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BIOPX vs. AWYIX - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
BIOPX
Baron Opportunity Fund
11.24%19.44%39.87%49.55%-42.96%11.90%88.78%40.34%-1.03%
AWYIX
CIBC Atlas Equity Income Fund
2.05%7.66%18.19%16.39%-15.59%29.51%12.75%35.07%1.12%

Correlation

The correlation between BIOPX and AWYIX is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.43

Correlation (3Y)
Calculated over the trailing 3-year period

0.57

Correlation (5Y)
Calculated over the trailing 5-year period

0.66

Correlation (All Time)
Calculated using the full available price history since Mar 28, 2018

0.69

Over the past year, the correlation between BIOPX and AWYIX has dropped to 0.43 - well below their long-term average of 0.69, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIOPX vs. AWYIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIOPX
BIOPX Risk / Return Rank: 3232
Overall Rank
BIOPX Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
BIOPX Sortino Ratio Rank: 3131
Sortino Ratio Rank
BIOPX Omega Ratio Rank: 3232
Omega Ratio Rank
BIOPX Calmar Ratio Rank: 3232
Calmar Ratio Rank
BIOPX Martin Ratio Rank: 3030
Martin Ratio Rank

AWYIX
AWYIX Risk / Return Rank: 1515
Overall Rank
AWYIX Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
AWYIX Sortino Ratio Rank: 1414
Sortino Ratio Rank
AWYIX Omega Ratio Rank: 1414
Omega Ratio Rank
AWYIX Calmar Ratio Rank: 1414
Calmar Ratio Rank
AWYIX Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIOPX vs. AWYIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Baron Opportunity Fund (BIOPX) and CIBC Atlas Equity Income Fund (AWYIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIOPXAWYIXDifference
Sharpe ratioReturn per unit of total volatility

+0.58

Sortino ratioReturn per unit of downside risk

+0.76

Omega ratioGain probability vs. loss probability

1.30

1.19

+0.10

Calmar ratioReturn relative to maximum drawdown

2.14

1.27

+0.87

Martin ratioReturn relative to average drawdown

7.06

4.74

+2.32

BIOPX vs. AWYIX - Sharpe Ratio Comparison

The current BIOPX Sharpe Ratio is 1.65, which is higher than the AWYIX Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of BIOPX and AWYIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BIOPXAWYIXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.65

1.07

+0.58

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.44

0.54

-0.10

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.87

Sharpe Ratio (All Time)

Calculated using the full available price history

0.41

0.68

-0.27

Drawdowns

BIOPX vs. AWYIX - Drawdown Comparison

The maximum BIOPX drawdown since its inception was -67.91%, which is greater than AWYIX's maximum drawdown of -35.79%. Use the drawdown chart below to compare losses from any high point for BIOPX and AWYIX.


Loading charts...

Drawdown Indicators


BIOPXAWYIXDifference

Max Drawdown

Largest peak-to-trough decline

-67.91%

-35.79%

-32.12%

Max Drawdown (1Y)

Largest decline over 1 year

-14.16%

-8.35%

-5.81%

Max Drawdown (3Y)

Largest decline over 3 years

-26.34%

-18.72%

-7.62%

Max Drawdown (5Y)

Largest decline over 5 years

-51.45%

-19.82%

-31.63%

Max Drawdown (10Y)

Largest decline over 10 years

-51.45%

Current Drawdown

Current decline from peak

-0.05%

-1.02%

+0.97%

Average Drawdown

Average peak-to-trough decline

-16.88%

-5.02%

-11.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.27%

2.23%

+2.04%

Volatility

BIOPX vs. AWYIX - Volatility Comparison

Baron Opportunity Fund (BIOPX) has a higher volatility of 3.29% compared to CIBC Atlas Equity Income Fund (AWYIX) at 2.32%. This indicates that BIOPX's price experiences larger fluctuations and is considered to be riskier than AWYIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BIOPXAWYIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.29%

2.32%

+0.97%

Volatility (6M)

Calculated over the trailing 6-month period

12.89%

7.44%

+5.45%

Volatility (1Y)

Calculated over the trailing 1-year period

18.30%

9.88%

+8.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.69%

14.42%

+12.27%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.85%

17.88%

+6.97%

BIOPX vs. AWYIX - Expense Ratio Comparison

BIOPX has a 1.31% expense ratio, which is higher than AWYIX's 0.95% expense ratio.


Dividends

BIOPX vs. AWYIX - Dividend Comparison

BIOPX's dividend yield for the trailing twelve months is around 3.81%, more than AWYIX's 2.14% yield.


PositionTTM20252024202320222021202020192018201720162015
AWYIX
CIBC Atlas Equity Income Fund
2.14%1.74%5.77%1.80%3.23%6.35%6.87%3.82%6.79%0.00%0.00%0.00%
BIOPX
Baron Opportunity Fund
3.81%4.24%4.95%0.00%0.00%8.71%6.96%7.33%5.29%15.58%13.52%10.92%

Frequently Asked Questions


BIOPX and AWYIX have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BIOPX has higher volatility (3.29%) compared to AWYIX (2.32%). In terms of maximum drawdown, BIOPX dropped -67.91% vs AWYIX's -35.79%.

BIOPX currently has the higher Sharpe Ratio (1.65 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BIOPX and AWYIX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer